{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:05:19Z","timestamp":1790179519485,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100016714","name":"University of Sharjah","doi-asserted-by":"publisher","award":["25010901180"],"award-info":[{"award-number":["25010901180"]}],"id":[{"id":"10.13039\/100016714","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"DOI":"10.1007\/s12031-026-02584-z","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T02:58:50Z","timestamp":1785985130000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma CAF22 Predicts Incident Freezing of Gait in Parkinson\u2019s Disease: A Prospective Cohort Study"],"prefix":"10.1007","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8485-7172","authenticated-orcid":false,"given":"Rizwan","family":"Qaisar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Shahid","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asima","family":"Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firdos","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"issue":"2","key":"2584_CR2","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/mds.70096","volume":"41","author":"MS Alam","year":"2026","unstructured":"Alam MS, Yu L, Stebbins GT, Mestre TA, Goetz CG, Luo S (2026) Longitudinal Evaluation of an Abbreviated Patient-Reported Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS) for Predicting Dopaminergic Therapy Initiation in Early Parkinson\u2019s Disease. Mov Disord 41(2):426\u2013435","journal-title":"Mov Disord"},{"issue":"10","key":"2584_CR3","doi-asserted-by":"publisher","first-page":"e13225","DOI":"10.1111\/acel.13225","volume":"19","author":"S Bhaskaran","year":"2020","unstructured":"Bhaskaran S, Pollock N, P CM, Ahn B, Piekarz KM, Staunton CA, Brown JL, Qaisar R, Vasilaki A, Richardson A, McArdle A, Jackson MJ, Brooks SV, Van Remmen H (2020) Neuron-specific deletion of CuZnSOD leads to an advanced sarcopenic phenotype in older mice. Aging Cell 19(10):e13225","journal-title":"Aging Cell"},{"issue":"4","key":"2584_CR4","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/ageing\/afz046","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni MP Writing Group for the European Working Group on Sarcopenia in Older and E. the Extended Group for (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48(4):601","journal-title":"Age Ageing"},{"issue":"1","key":"2584_CR5","doi-asserted-by":"publisher","first-page":"e13707","DOI":"10.1002\/jcsm.13707","volume":"16","author":"R Fatima","year":"2025","unstructured":"Fatima R, Kim Y, Baek S, Suram RP, An SL, Hong Y (2025) C-Terminal Agrin Fragment as a Biomarker for Sarcopenia: A Systematic Review and Meta-Analysis. J Cachexia Sarcopenia Muscle 16(1):e13707","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2584_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40035-020-00191-5","volume":"9","author":"C Gao","year":"2020","unstructured":"Gao C, Liu J, Tan Y, Chen S (2020) Freezing of gait in Parkinson\u2019s disease: pathophysiology, risk factors and treatments. Transl Neurodegener 9:12","journal-title":"Transl Neurodegener"},{"issue":"Suppl 2","key":"2584_CR7","doi-asserted-by":"publisher","first-page":"S423","DOI":"10.1002\/mds.21927","volume":"23","author":"N Giladi","year":"2008","unstructured":"Giladi N, Nieuwboer A (2008) Understanding and treating freezing of gait in parkinsonism, proposed working definition, and setting the stage. Mov Disord 23(Suppl 2):S423\u2013425","journal-title":"Mov Disord"},{"issue":"4","key":"2584_CR8","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1007\/s12031-022-01970-7","volume":"72","author":"A Karim","year":"2022","unstructured":"Karim A, Iqbal MS, Muhammad T, Qaisar R (2022) Evaluation of Sarcopenia Using Biomarkers of the Neuromuscular Junction in Parkinson\u2019s Disease. J Mol Neurosci 72(4):820\u2013829","journal-title":"J Mol Neurosci"},{"key":"2584_CR9","doi-asserted-by":"publisher","first-page":"791679","DOI":"10.1155\/2013\/791679","volume":"2013","author":"P Kwan","year":"2013","unstructured":"Kwan P (2013) Sarcopenia, a neurogenic syndrome? J Aging Res 2013:791679","journal-title":"J Aging Res"},{"issue":"2","key":"2584_CR10","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3233\/JPD-191813","volume":"10","author":"SR Lord","year":"2020","unstructured":"Lord SR, Bindels H, Ketheeswaran M, Brodie MA, Lawrence AD, Close JCT, Whone AL, Ben-Shlomo Y, Henderson EJ (2020) Freezing of Gait in People with Parkinson\u2019s Disease: Nature, Occurrence, and Risk Factors. J Parkinsons Dis 10(2):631\u2013640","journal-title":"J Parkinsons Dis"},{"issue":"2","key":"2584_CR11","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/jcsm.13189","volume":"14","author":"E Monti","year":"2023","unstructured":"Monti E, Sarto F, Sartori R, Zanchettin G, Lofler S, Kern H, Narici MV, Zampieri S (2023) C-terminal agrin fragment as a biomarker of muscle wasting and weakness: a narrative review. J Cachexia Sarcopenia Muscle 14(2):730\u2013744","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2584_CR12","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.neubiorev.2016.07.010","volume":"68","author":"AA Moustafa","year":"2016","unstructured":"Moustafa AA, Chakravarthy S, Phillips JR, Gupta A, Keri S, Polner B, Frank MJ, Jahanshahi M (2016) Motor symptoms in Parkinson\u2019s disease: A unified framework. Neurosci Biobehav Rev 68:727\u2013740","journal-title":"Neurosci Biobehav Rev"},{"key":"2584_CR13","doi-asserted-by":"publisher","first-page":"122186","DOI":"10.1016\/j.lfs.2023.122186","volume":"333","author":"R Qaisar","year":"2023","unstructured":"Qaisar R (2023) Targeting neuromuscular junction to treat neuromuscular disorders. Life Sci 333:122186","journal-title":"Life Sci"},{"key":"2584_CR17","doi-asserted-by":"publisher","first-page":"107298","DOI":"10.1016\/j.rmed.2023.107298","volume":"215","author":"R Qaisar","year":"2023","unstructured":"Qaisar R, Karim A, Muhammad T, Alkahtani SA, Kamli H, Ahmad F (2023) Degradation of neuromuscular junction contributes to muscle weakness but not physical compromise in chronic obstructive pulmonary disease patients taking lipids-lowering medications. Respir Med 215:107298","journal-title":"Respir Med"},{"issue":"5","key":"2584_CR15","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s40291-024-00724-y","volume":"28","author":"R Qaisar","year":"2024","unstructured":"Qaisar R, Karim A, Iqbal MS, Ahmad F, Hussain MA (2024a) Tracking the Plasma C-Terminal Agrin Fragment as a Biomarker of Neuromuscular Decline in 18- to 87-Year-Old Men. Mol Diagn Ther 28(5):611\u2013620","journal-title":"Mol Diagn Ther"},{"key":"2584_CR16","doi-asserted-by":"publisher","first-page":"107510","DOI":"10.1016\/j.rmed.2023.107510","volume":"222","author":"R Qaisar","year":"2024","unstructured":"Qaisar R, Karim A, Muhammad T, Ahmad F (2024b) Butyrate supplementation reduces sarcopenia by repairing neuromuscular junction in patients with chronic obstructive pulmonary disease. Respir Med 222:107510","journal-title":"Respir Med"},{"issue":"8","key":"2584_CR14","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1002\/bcp.70065","volume":"91","author":"R Qaisar","year":"2025","unstructured":"Qaisar R, Karim A, Alkahtani SA, Khan IU, Ahmad F (2025) The improvement in muscle function following statin withdrawal might involve the repair of the neuromuscular junction. Br J Clin Pharmacol 91(8):2458\u20132468","journal-title":"Br J Clin Pharmacol"},{"key":"2584_CR18","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.hrtlng.2025.09.022","volume":"75","author":"R Qaisar","year":"2026","unstructured":"Qaisar R, Khan IU, Ahmad F, Karim A (2026) Asthma-chronic obstructive pulmonary disease overlap is associated with a higher degree of neuromuscular junction degradation than either disease alone. Heart Lung 75:164\u2013170","journal-title":"Heart Lung"},{"issue":"8","key":"2584_CR19","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.parkreldis.2014.04.009","volume":"20","author":"L Ricciardi","year":"2014","unstructured":"Ricciardi L, Bloem BR, Snijders AH, Daniele A, Quaranta D, Bentivoglio AR, Fasano A (2014) Freezing of gait in Parkinson\u2019s disease: the paradoxical interplay between gait and cognition. Parkinsonism Relat Disord 20(8):824\u2013829","journal-title":"Parkinsonism Relat Disord"},{"key":"2584_CR20","doi-asserted-by":"publisher","first-page":"610964","DOI":"10.3389\/fnmol.2020.610964","volume":"13","author":"PM Rodriguez Cruz","year":"2020","unstructured":"Rodriguez Cruz PM, Cossins J, Beeson D, Vincent A (2020) The Neuromuscular Junction in Health and Disease: Molecular Mechanisms Governing Synaptic Formation and Homeostasis. Front Mol Neurosci 13:610964","journal-title":"Front Mol Neurosci"},{"issue":"14","key":"2584_CR21","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1080\/09638288.2023.2242257","volume":"46","author":"AE Scully","year":"2024","unstructured":"Scully AE, Tan DML, de Oliveira BI, Hill KD, Clark R, Pua YH (2024) Validity and reliability of a new clinician-rated tool for freezing of gait severity. Disabil Rehabil 46(14):3133\u20133140","journal-title":"Disabil Rehabil"},{"key":"2584_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cophys.2018.05.007","volume":"4","author":"T Taetzsch","year":"2018","unstructured":"Taetzsch T, Valdez G (2018) NMJ maintenance and repair in aging. Curr Opin Physiol 4:57\u201364","journal-title":"Curr Opin Physiol"},{"issue":"15","key":"2584_CR23","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","volume":"25","author":"CL Tomlinson","year":"2010","unstructured":"Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease. Mov Disord 25(15):2649\u20132653","journal-title":"Mov Disord"},{"issue":"10","key":"2584_CR1","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s12603-009-0246-z","volume":"13","author":"G van Abellan","year":"2009","unstructured":"van Abellan G, Rolland Y, Andrieu S, Bauer J, Beauchet O, Bonnefoy M, Cesari M, Donini LM, Gillette Guyonnet S, Inzitari M, Nourhashemi F, Onder G, Ritz P, Salva A, Visser M, Vellas B (2009) Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging 13(10):881\u2013889","journal-title":"J Nutr Health Aging"},{"issue":"5","key":"2584_CR24","first-page":"1","volume":"9","author":"C Varadi","year":"2020","unstructured":"Varadi C (2020) Clinical Features of parkinson\u2019s disease. Evol Crit Symptoms Biol (Basel) 9(5):1\u201313","journal-title":"Evol Crit Symptoms Biol (Basel)"},{"issue":"1","key":"2584_CR25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1590\/1980-57642018dn13-010008","volume":"13","author":"KA Vasquez","year":"2019","unstructured":"Vasquez KA, Valverde EM, Aguilar DV, Gabarain HH (2019) Montreal Cognitive Assessment scale in patients with Parkinson Disease with normal scores in the Mini-Mental State Examination. Dement Neuropsychol 13(1):78\u201381","journal-title":"Dement Neuropsychol"},{"issue":"20","key":"2584_CR26","first-page":"2191","volume":"310","author":"A World Medical","year":"2013","unstructured":"World Medical A (2013) World Medical Association Declaration of Helsinki: ethical principles for medical research. involving Hum Subj JAMA 310(20):2191\u20132194","journal-title":"involving Hum Subj JAMA"},{"issue":"4","key":"2584_CR27","doi-asserted-by":"publisher","first-page":"302","DOI":"10.2174\/1570159X14666151201190040","volume":"14","author":"LL Zhang","year":"2016","unstructured":"Zhang LL, Canning SD, Wang XP (2016) Freezing of Gait in Parkinsonism and its Potential Drug Treatment. Curr Neuropharmacol 14(4):302\u2013306","journal-title":"Curr Neuropharmacol"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-026-02584-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12031-026-02584-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-026-02584-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:34:53Z","timestamp":1790177693000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12031-026-02584-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":27,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["2584"],"URL":"https:\/\/doi.org\/10.1007\/s12031-026-02584-z","relation":{},"ISSN":["1559-1166"],"issn-type":[{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"assertion":[{"value":"9 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"standards committee\n                      : An ethics approval was obtained from the Clinical Research Ethics Committee of Rehman Medical Institute (Reference No. HREC-24-04-03-03, approved on 11th February 2023).","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"An ethics approval was obtained from the Clinical Research Ethics Committee of Rehman Medical Institute (Reference No. HREC-24-04-03-03, approved on 11th February 2023). All participants provided written informed consent.","order":2,"name":"Ethics","label":"Human Ethics and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical Trial Number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"126"}}